Cargando…
Growth Suppression of Glioma Cells Using HDAC6 Inhibitor, Tubacin
In cancer research, autophagy has been revealed as one of the major ways to maintain the metabolism of cancer cells, including glioma cells, through protein degradation. Meanwhile, autophagy is also regarded as a kind of mechanism to protect glioma cells from a harmful stimulus, such as chemical and...
Autores principales: | Yin, Changjiang, Li, Pibao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter Open
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968415/ https://www.ncbi.nlm.nih.gov/pubmed/29845122 http://dx.doi.org/10.1515/med-2018-0034 |
Ejemplares similares
-
Suppression of FGFR3- and MYC-dependent oncogenesis by tubacin: association with HDAC6-dependent and independent activities
por: Ota, Sara, et al.
Publicado: (2017) -
Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis
por: Lu, Chien-Yi, et al.
Publicado: (2017) -
Quatramer™ encapsulation of dual‐targeted PI3‐Kδ/HDAC6 inhibitor, HSB‐510, suppresses growth of breast cancer
por: Tiwari, Sachchidanand, et al.
Publicado: (2023) -
HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma
por: Garrett, Matthew C., et al.
Publicado: (2023) -
The HDAC Inhibitor, SAHA, Prevents Colonic Inflammation by Suppressing Pro-inflammatory Cytokines and Chemokines in DSS-induced Colitis
por: Ali, Mohmand Noor, et al.
Publicado: (2018)